A role for phosphoinositol 3–kinase δ in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease
John A. Marwick(Queen's Medical Centre), Alberto Papi(University of Ferrara)
Cited by 106
Related Papers
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
|New England Journal of Medicine|2024|240
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2015|217